Thoracic Cancer Trial
Non-Squamous Non-Small Cell
A Randomized Phase II Trial of Cabozantinib and Cabozantinib plus Nivolumab versus Standard Chemotherapy in Patients with Previously Treated Non-Squamous NSCLC
Physician and Research Staff Educational Material:
This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.
Information and Assistance from the National Cancer Institute:
- Locations and other information (coming soon)
- Trained information specialists at the NCI are available to answer cancer-related questions from patients, family members or friends, health care providers, and researchers. Visit the NCI’s Cancer Information Service webpage for contact instructions, including telephone, live chat, email, and mail.